Total cerebral blood flow and mortality in old age A 12-year follow-up study

Neurology

Volumn 81, Issue 22, 2013, Pages 1922-1929

  Sabayan, Behnam ^a,b   Grond, Jeroen Van Der ^a   Westendorp, Rudi G ^b,d   Jukema, J Wouter ^c   Ford, Ian ^e   Buckley, Brendan M ^g   Sattar, Naveed ^f   Van Osch, Matthias J P ^a   Van Buchem, Mark A ^a   De Craen, Anton J M ^a,d  

^a Onze Lieve Vrouwe Gasthuis   (Netherlands)

^b Department of Internal Medicine   (Netherlands)

^c Departments of Cardiology   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

10th revision; CBF 5 cerebral blood flow; CI 5 confidence interval; FLAIR 5 fluid attenuated inversion recovery; FOV 5 field of view; ICD 10 5 International Classification of Diseases and Related Disorders; PROSPER 5 Prospective Study of Pravastatin in the Elderly at Risk; ROI 5 region of interest; TE 5 echo time; TR 5 repetition time.

Indexed keywords

AGED; ARTICLE; BODY MASS; BRAIN BLOOD FLOW; BRAIN SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEATH; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SENESCENCE; SENSITIVITY ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; BRAIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR CIRCULATION; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PRAVASTATIN; RISK FACTORS;

EID: 84891925493     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436618.48402.da     Document Type: Article

References (30)

1. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 2010;468:232-243.
2. Erecinska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 2001;128:263-276.
3. Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 2007;54:162-180.
4. Shin JS, Hyun SY, Kim DH, et al. Chronic hypoperfusion increases claudin-3 immunoreactivity in rat brain. Neurosci Lett 2008;445:144-148.
5. Downard C, Hulka F, Mullins RJ, et al. Relationship of cerebral perfusion pressure and survival in pediatric braininjured patients. J Trauma 2000;49:654-658.
6. Markus HS. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry 2004;75:353-361.
7. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88:107-115.
8. Cao JJ, Arnold AM, Manolio TA, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007; 116:32-38.
9. Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 1999;84:1192-1197.
10. ten Dam VH, Box FM, de Craen AJ, et al. Lack of effect of pravastatin on cerebral blood flow or parenchymal volume loss in elderly at risk for vascular disease. Stroke 2005; 36:1633-1636.
11. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1): S208-S219.
12. Admiraal-Behloul F, van den Heuvel DM, Olofsen H, et al. Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 2005; 28:607-617.
13. Bakker CJ, Kouwenhoven M, Hartkamp MJ, Hoogeveen RM, Mali WP. Accuracy and precision of time-averaged flow as measured by nontriggered 2D phase-contrast MR angiography, a phantom evaluation. Magn Reson Imaging 1995;13:959-965.
14. Spilt A, Box FM, van der Geest RJ, et al. Reproducibility of total cerebral blood flow measurements using phase contrast magnetic resonance imaging. J Magn Reson Imaging 2002;16:1-5.
15. Pfister R, Schneider CA. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Eur Heart J 2009;30:382-383.
16. van Es AC, van der Grond J, ten Dam VH, et al. Associations between total cerebral blood flow and age related changes of the brain. PLoS One 2010;5:e9825.
17. Sabayan B, Jansen S, Oleksik AM, et al. Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing Res Rev 2012;11:271-277.
18. Weiller C, Ringelstein EB, Reiche W, Buell U. Clinical and hemodynamic aspects of low-flow infarcts. Stroke 1991;22:1117-1123.
19. Kim MS, Kim JS, Yun SC, et al. Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure. Eur Heart J 2012;33:354-362.
20. Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 2011;10: 187-198.
21. Pase MP, Grima NA, Stough CK, Scholey A, Pipingas A. Cardiovascular disease risk and cerebral blood flow velocity. Stroke 2012;43:2803-2805.
22. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 2000;69:48-53.
23. Ackerman RH. Cerebral blood flow and neurological change in chronic heart failure. Stroke 2001;32:2462-2464.
24. Muller M, van der Graaf Y, Visseren FL, Mali WP, Geerlings MI. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann Neurol 2012;71:825-833.
25. Lam TK. Neuronal regulation of homeostasis by nutrient sensing. Nat Med 2010;16:392-395.
26. Sekhon LH, Morgan MK, Spence I, Weber NC. Chronic cerebral hypoperfusion: pathological and behavioral consequences. Neurosurgery 1997;40:548-556.
27. Becher B, Prat A, Antel JP. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 2000;29:293-304.
28. Abizaid A, Horvath TL. Brain circuits regulating energy homeostasis. Regul Pept 2008;149:3-10.
29. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009;10:397-409.
30. Cechetti F, Pagnussat AS, Worm PV, et al. Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull 2012;87:109-116.